Botulinum toxin is the bacterial toxin secreted by the deadly botulinum toxin, action on the end of the cholinergic nerve, antagonism calcium ion, interference acetylcholine release, make muscle fiber cannot contract cause muscle relaxation, achieve the purpose of wrinkle beauty.Botox was first used as a biological weapon, and was later used by the medical community to treat facial cramps and other muscle-movement disorders. In the 1980s, the plastic surgery community expanded its function, using it to thin the face and shape the legs.China is the third country after the United Kingdom and the United States to produce its own botox cosmetic products, and began to use in 1999.In recent years, global botulinum toxin type A has developed rapidly, with an average growth rate of about 15%. In 2017, global production of botulinum toxin type A was 22.35 million bottles, with an output value of $4 billion.The price of botulinum toxin type A has been on A downward trend due to the economic environment, the improvement of people's health level and the influx of low-end products into the market, with the price dropping from $194 / bottle in 2013 to $178 / bottle in 2017.We expect prices to continue to fall over the next few years as domestic players get bigger and stronger and new products emerge.There are three main types of botulinum toxin A products: 50 units, 100 units and others.Of these, 50 units accounted for the largest share, accounting for 59% of the market in 2017.Botulinum toxin A is used mainly for medical and cosmetic purposes.Medical use accounted for the majority, accounting for about 51% of the total market in 2017.The United States is the top sales region, accounting for 54 percent of global sales in 2017.In 2017, China accounted for 5 percent of global production, while China accounted for 9 percent of global sales. China is an importer.North America is also a major consumer region, but due to the high development level in these regions, the annual growth rate is relatively flat. Currently, there are only two kinds of botox approved in China, namely the balance of lanzhou institute of biological products and the protection of allergan, which have not changed in recent years.Due to the larger dispersion, it is suitable for the injection of larger muscles and itself, such as thin face, thin leg, and the cost of weight is cheap, cost-effective;However, the dispersivity of propofol is small, which is suitable for accurate injection such as wrinkle removal.At present, allergan, ipson, Merz Pharmaceuticals, Medytox, lanzhou hengli and other industrial giants represented by the products occupy the mainstream position in the international market.
The global market for Botulinum Toxin A was estimated to be worth US$ 6563.4 million in 2023 and is forecast to a readjusted size of US$ 15790 million by 2030 with a CAGR of 13.2% during the forecast period 2024-2030
Global Botulinum Toxin A key players include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc.
United States is the largest market, with a share about 75%, followed by China, and Europe, both have a share about 20 percent.
In terms of product, 50iu is the largest segment, with a share about 60%. And in terms of application, the largest application is Medical Use, followed by Beauty Use.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Botulinum Toxin A, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Botulinum Toxin A by region & country, by Type, and by Application.
The Botulinum Toxin A market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Botulinum Toxin A.
Market Segmentation
By Company
Allergan (AGN)
Ipsen
Merz Pharmaceuticals
Medytox
BTXA
Segment by Type:
50iu
100iu
Other
Segment by Application
Medical Use
Beauty Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Botulinum Toxin A manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Botulinum Toxin A in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Botulinum Toxin A in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Botulinum Toxin A Product Introduction
1.2 Global Botulinum Toxin A Market Size Forecast
1.3 Botulinum Toxin A Market Trends & Drivers
1.3.1 Botulinum Toxin A Industry Trends
1.3.2 Botulinum Toxin A Market Drivers & Opportunity
1.3.3 Botulinum Toxin A Market Challenges
1.3.4 Botulinum Toxin A Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Botulinum Toxin A Players Revenue Ranking (2023)
2.2 Global Botulinum Toxin A Revenue by Company (2019-2024)
2.3 Key Companies Botulinum Toxin A Manufacturing Base Distribution and Headquarters
2.4 Key Companies Botulinum Toxin A Product Offered
2.5 Key Companies Time to Begin Mass Production of Botulinum Toxin A
2.6 Botulinum Toxin A Market Competitive Analysis
2.6.1 Botulinum Toxin A Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Botulinum Toxin A Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botulinum Toxin A as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 50iu
3.1.2 100iu
3.1.3 Other
3.2 Global Botulinum Toxin A Sales Value by Type
3.2.1 Global Botulinum Toxin A Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Botulinum Toxin A Sales Value, by Type (2019-2030)
3.2.3 Global Botulinum Toxin A Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical Use
4.1.2 Beauty Use
4.2 Global Botulinum Toxin A Sales Value by Application
4.2.1 Global Botulinum Toxin A Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Botulinum Toxin A Sales Value, by Application (2019-2030)
4.2.3 Global Botulinum Toxin A Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Botulinum Toxin A Sales Value by Region
5.1.1 Global Botulinum Toxin A Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Botulinum Toxin A Sales Value by Region (2019-2024)
5.1.3 Global Botulinum Toxin A Sales Value by Region (2025-2030)
5.1.4 Global Botulinum Toxin A Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Botulinum Toxin A Sales Value, 2019-2030
5.2.2 North America Botulinum Toxin A Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Botulinum Toxin A Sales Value, 2019-2030
5.3.2 Europe Botulinum Toxin A Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Botulinum Toxin A Sales Value, 2019-2030
5.4.2 Asia Pacific Botulinum Toxin A Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Botulinum Toxin A Sales Value, 2019-2030
5.5.2 South America Botulinum Toxin A Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Botulinum Toxin A Sales Value, 2019-2030
5.6.2 Middle East & Africa Botulinum Toxin A Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Botulinum Toxin A Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Botulinum Toxin A Sales Value
6.3 United States
6.3.1 United States Botulinum Toxin A Sales Value, 2019-2030
6.3.2 United States Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Botulinum Toxin A Sales Value, 2019-2030
6.4.2 Europe Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Botulinum Toxin A Sales Value, 2019-2030
6.5.2 China Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.5.3 China Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Botulinum Toxin A Sales Value, 2019-2030
6.6.2 Japan Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Botulinum Toxin A Sales Value, 2019-2030
6.7.2 South Korea Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Botulinum Toxin A Sales Value, 2019-2030
6.8.2 Southeast Asia Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Botulinum Toxin A Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Botulinum Toxin A Sales Value, 2019-2030
6.9.2 India Botulinum Toxin A Sales Value by Type (%), 2023 VS 2030
6.9.3 India Botulinum Toxin A Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan (AGN)
7.1.1 Allergan (AGN) Profile
7.1.2 Allergan (AGN) Main Business
7.1.3 Allergan (AGN) Botulinum Toxin A Products, Services and Solutions
7.1.4 Allergan (AGN) Botulinum Toxin A Revenue (US$ Million) & (2019-2024)
7.1.5 Allergan (AGN) Recent Developments
7.2 Ipsen
7.2.1 Ipsen Profile
7.2.2 Ipsen Main Business
7.2.3 Ipsen Botulinum Toxin A Products, Services and Solutions
7.2.4 Ipsen Botulinum Toxin A Revenue (US$ Million) & (2019-2024)
7.2.5 Ipsen Recent Developments
7.3 Merz Pharmaceuticals
7.3.1 Merz Pharmaceuticals Profile
7.3.2 Merz Pharmaceuticals Main Business
7.3.3 Merz Pharmaceuticals Botulinum Toxin A Products, Services and Solutions
7.3.4 Merz Pharmaceuticals Botulinum Toxin A Revenue (US$ Million) & (2019-2024)
7.3.5 Medytox Recent Developments
7.4 Medytox
7.4.1 Medytox Profile
7.4.2 Medytox Main Business
7.4.3 Medytox Botulinum Toxin A Products, Services and Solutions
7.4.4 Medytox Botulinum Toxin A Revenue (US$ Million) & (2019-2024)
7.4.5 Medytox Recent Developments
7.5 BTXA
7.5.1 BTXA Profile
7.5.2 BTXA Main Business
7.5.3 BTXA Botulinum Toxin A Products, Services and Solutions
7.5.4 BTXA Botulinum Toxin A Revenue (US$ Million) & (2019-2024)
7.5.5 BTXA Recent Developments
8 Industry Chain Analysis
8.1 Botulinum Toxin A Industrial Chain
8.2 Botulinum Toxin A Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Botulinum Toxin A Sales Model
8.5.2 Sales Channel
8.5.3 Botulinum Toxin A Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Allergan (AGN)
Ipsen
Merz Pharmaceuticals
Medytox
BTXA
*If Applicable.